Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 2019. (26th May 2022)

• Record Type: Journal Article
• Authors: Kaku, Norihito; Sasaki, Daisuke; Ota, Kenji; Miyazaki, Taiga; Yanagihara, Katsunori
• Is Part Of: Journal of antimicrobial chemotherapy. Volume 77:Number 8(2022)
• Page Start: 2130
• Page End: 2141
• Publication Date: 2022-05-26
• Subjects: Anti-infective agents -- Periodicals; Chemotherapy -- Periodicals; 615.58
• DOI: 10.1093/jac/dkac154
• Languages: English
• ISSNs: 0305-7453

Abstract

Abstract: Objectives: Some single-centre studies have reported that MRSA carrying the staphylococcal cassette chromosome mec (SCC mec ) type IV has been increasing in bloodstream infections (BSIs) in Japan. Therefore, we conducted nationwide surveillance for MRSA BSIs to investigate the extent of such change across Japan. Methods: We recruited 51 Japanese hospitals from the Japanese Association for Infectious Diseases. MRSA isolates detected in two or more sets of blood cultures were collected between January and September 2019 and subjected to antimicrobial susceptibility testing. WGS was also performed to determine SCC mec and MLST types and detect drug-resistance and virulence genes. Results: Two hundred and seventy MRSA isolates were collected from 45 hospitals. The major combination types were ST8 with SCC mec type IV (ST8-IV) (30.7%), ST1-IV (29.6%), ST2725-IV (9.5%), ST764-II (8.1%) and ST5-II (7.8%). However, there were regional differences among the major types. The most common types in eastern, western and northern Japan were ST1-IV, ST8-IV, and ST5-II and ST764-II, respectively. ST8-IV, ST1-IV and ST2725-IV exhibited greater susceptibility to clindamycin and minocycline than ST764-II and ST5-II, but erm (A) was detected in 93.8% and 100.0% of ST1-IV and ST2725-IV, respectively. Based on drug-resistance and virulence genes, characteristics of ST8-IV were different from those of ST1-IV and ST2725-IV. In addition, there were two major ST8-IV types with different characteristics. Conclusions: This study revealed that SCC mec type IV replaced SCC mec type II in MRSA BSIs. In addition, SCC mec type IV was divided into several types with different characteristics.